Recruiting
Acquired antithrombin III deficiency+1
RecruitingStudy on Antithrombin III Human for Patients with Heparin Resistance Undergoing Cardiac Surgery with Cardiopulmonary Bypass
Registered drug
Study on Antithrombin III Human for Patients with Heparin Resistance Undergoing Cardiac Surgery with Cardiopulmonary Bypass
Registered drug
- Disease:Acquired antithrombin III deficiencyHeparin resistance
- Substances:Sodium ChlorideAntithrombin Iii Human
Countries:
Austria
Austria- Participants:18–64 years · 65+ years
- Substances:Sodium Chloride
- Sponsor:Octapharma AG
